Top Suppliers:I want be here

923262-96-8

923262-96-8 structure
923262-96-8 structure
  • Name: SAR407899 (hydrochloride)
  • Chemical Name: 6-piperidin-4-yloxy-2H-isoquinolin-1-one,hydrochloride
  • CAS Number: 923262-96-8
  • Molecular Formula: C14H17ClN2O2
  • Molecular Weight: 280.75000
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage ROCK
  • Create Date: 2018-11-26 18:14:35
  • Modify Date: 2024-01-14 02:01:50
  • SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.

Name 6-piperidin-4-yloxy-2H-isoquinolin-1-one,hydrochloride
Synonyms qc-9996
SAR407899
SAR407899 (hydrochloride)
Description SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.
Related Catalog
Target

ROCK-2:102 nM (IC50)

ROCK-1:276 nM (IC50)

In Vitro SAR407899 hydrochloride is a potent and ATP-competitive ROCK inhibitor, with Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively. SAR407899 inhibits ROCK-2 better than ROCK-1, with IC50s of 102±19 nM and 276±26 nM, respectively, in the presence of 40 μM ATP. SAR407899 also less potently inhibits PKC-Δ and MSK-1, with IC50s of 5.4 and 3.1 μM, respectively. SAR407899 (0.1, 0.3, 1.0, and 3.0 μM) specifically inhibits the ROCK-mediated phosphorylation of MYPTT696 in HeLa cells stimulated with PHEN, and shows such effects at 1 μM and 10 μM in primary rat aortic smooth muscle cells. SAR407899 (3 μM) completely blocks thrombin-induced shrinkage of human umbilical vein endothelial cells (HUVECs) and stress fiber formation. SAR407899 concentration-dependently inhibits 5-bromodeoxyuridine incorporation into the cells with an IC50 of 5.0±1.3 μM. SAR407899 also effectively inhibits THP-1 migration with an IC50 of 2.5±1.0 μM. SAR407899 shows a potent vasorelaxant activity in a broad variety of isolated arteries taken from different vascular beds and species, with a range of IC50 values between 122 and 280 nM[1]. SAR407899 dose-dependently relaxes the phenylephrine pre-contracted smooth muscle, with IC50s of 0.07 and 0.05 μM, respectively[2].
In Vivo SAR407899 (3 mg/kg, i.v.) inhibits ROCK-mediated phosphorylation of MYPTT696 in thoracic aorta of spontaneously hypertensive rats (SHRs). SAR407899 (0.01-0.30 mg/kg, i.v.) efficiently reduces pressor responses to vasoconstrictor agents in rats. SAR407899 (1, 3, 10, and 30 mg/kg, p.o.) dose dependently lowers blood pressure in hypertensive SHRs[1]. SAR407899 (1-3 mg/kg, i.v. or 3, 10 mg/kg, p.o.) increases the length of the penis in healthy rabbits. SAR407899 (3-10 mg/kg, p.o.) also dose-dependently increases penile length in diabetic rabbits[2].
Animal Admin Rabbits are treated either intravenously (i.v., in an ear vein) with increasing doses of SAR407899 (0.3, 1, 3, 10 mg/kg) or orally with SAR407899 (1, 3, 10, 30 mg/kg) or sildenafil (2 or 6 mg/kg). Each animal is used several times for different doses and different agents, always with a week's washout. The length (mm) of uncovered penile mucosa (penile erection parameter) is measured at different time-points, using a sliding digital caliper. The results are expressed as mean ± SEM penile length of 3-5 rabbits[2].
References

[1]. L?hn M, et al. Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor. Hypertension. 2009 Sep;54(3):676-83.

[2]. Guagnini F, et al. Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa. J Transl Med. 2012 Mar 23;10:59.

[3]. Chen W, et al. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.Transpl Immunol. 2018 Jun 6. pii: S0966-3274(18)30029-7.

Molecular Formula C14H17ClN2O2
Molecular Weight 280.75000
Exact Mass 280.09800
PSA 54.12000
LogP 2.78970
HS Code 2933990090

~%

923262-96-8 structure

923262-96-8

Literature: SANOFI; GESSLER, Dr., Simon; WOLLMANN, Dr., Theo Patent: WO2013/7502 A1, 2013 ; Location in patent: Page/Page column 22 ;

~%

923262-96-8 structure

923262-96-8

Literature: SANOFI-AVENTIS Patent: WO2008/77550 A1, 2008 ; Location in patent: Page/Page column 62-63 ; WO 2008/077550 A1

~%

923262-96-8 structure

923262-96-8

Literature: SANOFI; GESSLER, Dr., Simon; WOLLMANN, Dr., Theo Patent: WO2013/7502 A1, 2013 ;

~%

923262-96-8 structure

923262-96-8

Literature: SANOFI; GESSLER, Dr., Simon; WOLLMANN, Dr., Theo Patent: WO2013/7502 A1, 2013 ;
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%